Professor David Ball is a consultant radiation oncologist and Chair of the multidisciplinary Lung Service at the Peter MacCallum Cancer Centre, Melbourne. He is also Deputy Director of the Division of Radiation Oncology and a Professorial Fellow of the Sir Peter MacCallum Department of Oncology within the University of Melbourne.
Since being appointed as Head of the Lung Service at Peter MacCallum Cancer Centre in 1981 DB has devoted the greater part of his professional career to the treatment of and research into lung cancer. Particular interests are lung cancer staging and prognostic factors; the use of PET scanning in the management of lung cancer; combined modality therapy involving radiation, chemotherapy and targeted agents; and stereotactic ablative body radiotherapy (SABR). Publication/presentation highlights
DB has over 200 peer reviewed publications with an H-index of 33. With Drs Harvey Pass and Giorgio Scagliotti, he is an editor of the definitive textbook “Thoracic Oncology” 2nd Edition published by the International Association for the Study of Lung Cancer mid 2017.
Top 5 publications 2008-2013;
1. Ball DL et al. The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05). Radiotherapy and Oncology 2013 106: 305-11. 2. Ball D et al. Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the Staging Project Database of the International Association for the Study of Lung Cancer. J Thorac Oncol. 2013;8:315–21.
3. Mac Manus M, Everitt S, Bayne M, Ball D, et al The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data. Radiotherapy and Oncology. 2013;106:292-98.
4. Mauguen A, Le Péchoux C, Saunders MI, Schild SE, Turrisi AT, Baumann M, Sause WT, Ball D et al. Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis. Journal of Clinical Oncology. 2012;30:2788-97.
5. Goldstraw P, Ball D, et al. Non-small-cell lung cancer. The Lancet. 2011;378:1727-40.
Honours and Awards
2008. Paula Pitt Award for Outstanding Contribution (Peter MacCallum Cancer Centre); 2010 Award for Outstanding Contribution (Trans Tasman Radiation Oncology Group); 2011 International Association for the Study of Lung Cancer (IASLC) Merit Award for an extraordinary contribution to the Association’s development; 2011 Gold Medal of the Royal Australian and New Zealand College of Radiologists; 2012 Tom Reeve Award for outstanding contribution to cancer care (Clinical Oncology Society of Australia – COSA).
Since 2007, DB has been Editor-in-Chief of the Journal of Medical Imaging and Radiation Oncology, the scientific journal of the Royal Australian New Zealand College of Radiologists. He has served on the editorial boards of Lung Cancer, Journal of Thoracic Oncology, Nature Clinical Practice Oncology and Clinical Lung Cancer.
DB was Secretary General of the Sixth World Conference on Lung Cancer held in Melbourne in 1991. He was President of the Trans Tasman Radiation Oncology Group (TROG) 2001 to 2007.He is currently Chair of the Australian Lung Cancer Guidelines Working Party which published the wiki-based treatment update late in 2012. He is a member of the Mesothelioma Guidelines Working Group.
He was a member of the IASLC staging committee which made recommendations to the UICC resulting in the revised 7th and 8th editions of the TNM staging manual.
DB iwas the current chair of Cancer Australia’s National Lung Cancer Advisory Group 2014-2017.
He was chair of the radiation oncology core program committee for the 18th World Conference on Lung Cancer held in Sydney 2013.
Fellow of Royal Australian and New Zealand College of Radiologists (FRANZCR), American Society for Therapeutic Radiology and Oncology (ASTRO), European Society for Therapeutic Radiology and Oncology (ESTRO), International Association for Study of Lung Cancer (IASLC), Australasian Lung Cancer Trials Group, TROG, COSA.